The global phototherapy lamps market size is likely to be valued at US$ 3.9 billion in 2026, and is projected to reach US$ 6.1 billion by 2033, growing at a CAGR of 6.6% during the forecast period 2026–2033.
The growth of the market is driven by the rising incidence of neonatal jaundice, increasing demand for dermatological phototherapy treatments, and wider adoption of light-emitting diode (LED) phototherapy technology in healthcare facilities. Hospitals and NICUs rely on phototherapy as a first-line treatment for neonatal hyperbilirubinemia, which affects a large percentage of newborns globally. Dermatologists also recommend UV phototherapy for chronic skin conditions such as psoriasis, vitiligo, and eczema. Clinical guidelines from pediatric and dermatology associations reinforce the role of light-based therapeutic devices in treatment protocols. Meanwhile, growing awareness of home-based phototherapy devices and advances in energy-efficient LED light sources are expanding access to phototherapy treatments worldwide.